Analyst Ratings for PRA Health Sciences Inc. (PRAH)

Updated: 2017-07-26

An average rating of Buy has been given to PRA Health Sciences Inc. (NASDAQ:PRAH) by analysts covering the stock. Last month, PRAH received an average rating of Buy.

8 analysts declared PRAH a buy, 1 gave an overweight rating, 1 gave a hold rating, 0 issued an underweight rating, and 0 issued a sell rating. Today, there are 1 more analysts optimistic about the company future as compared with 90 days ago. Over the same time period, there has been an increase of 0 in the number of analysts with a negative outlook on the stock.

Many analysts weighed in on price targets for PRAH. The most optimistic analyst gave a price target of 90, implying a possible profit of 17.17 percent. The most pessimistic analyst gave a price target of 69, implying a possible loss of -10.17 percent. Many analysts are not unbiased in their coverage of stocks, including price targets and stock ratings, so care must be taken in interpreting numbers released by them.

Analysts have revised their earnings estimates upwards for this quarter, by about 0 percent on average, compared to last month. The average change in earnings estimates over the last 90 days is -0.68 percent. Over the past 30 days, FY earnings estimates have also changed upwards by 0.16 percent. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes 0.32 percent.

People are often interested in whether analysts were united in the direction of their revisions. 0 analysts have revised their quarterly estimates upwards in the past 30 days, while 0 analysts revised their estimates downwards. Also over the last month, 0 analysts increased their estimates for the FY earnings, compared to 0 analysts that revised their FY estimates downwards.

PRAH has an estimated earnings growth rate of 79.29 percent as forecasted by analysts. People on Wall Street often look at a company's PEG ratio. Smaller PEG ratios are desirable, because that is often interpreted as the company being fairly priced relative to its growth rate. Wall Street investors typically prefer a PEG ratio to be smaller than 1, even though it may be more relevant to compare the ratio to that of a firm's competitors. PRAH has a PEG ratio of 0.57.

PRAH has traded between a high of 79.98 and a low of 43.08 over the past year. The current market price is above the trailing year's low by 78.3 percent, and 3.96 percent lower than its 52-week high. PRAH has a price/earnings ratio of 45.18. Investors typically compare the P/E ratio to a company's peers in the industry. The PRAH value stock report compares PRAH to some of its peers using value stock charts. The stock has a market capitalization of $4.8 billion. PRAH will post this quarters earnings in days, on 0000-00-00.